PHO-COG-FALLON-ANBL00B1; Neuroblastoma Biology Studies

Study on Biomarkers in Nerve Tissue Tumors

Recruiting
30 years or below
All
Phase N/A
1 Location

Brief description of study.

This research trial studies biomarkers in tumor tissue samples from patients with newly diagnosed neuroblastoma or ganglioneuroblastoma.

Detailed description of study

This research trial studies biomarkers in tumor tissue samples from patients with newly diagnosed neuroblastoma or ganglioneuroblastoma.

Participants will not be paid for their participation.
Participants will not be paid for their participation.
Participants will not be paid for their participation.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Neuroblastoma,Cancer,Oncology
  • Age: 30 years or below
  • Gender: All

Inclusion Criteria
Newly diagnosed with suspected neuroblastoma, suspected ganglionneuroblastoma
Exclusion Criteria
Patients with relapsed neuroblastoma who ere not enrolled on ANBL00B1 at original diagnosis

Updated on 19 Feb 2024. Study ID: 1011003226 (0012-27)

This study investigates the presence of biomarkers in tumor tissue samples from patients who have been newly diagnosed with neuroblastoma or ganglioneuroblastoma. Neuroblastoma is a type of cancer that forms in certain types of nerve tissue, while ganglioneuroblastoma is a similar condition that includes more mature cells. Biomarkers are substances that can indicate the presence or progression of a disease.

Participants in the study will have their tumor tissue samples analyzed to identify specific biomarkers. This process helps researchers understand the characteristics of these tumors and may guide future treatment options. There is no compensation for participating in this study.

  • Who can participate: Individuals who are newly diagnosed with suspected neuroblastoma or ganglioneuroblastoma are eligible to participate. Those with relapsed neuroblastoma who were not enrolled in the ANBL00B1 study at their original diagnosis cannot participate.
  • Study details: Participants will provide tumor tissue samples for biomarker analysis. This involves examining the samples to identify markers that could be important for understanding the disease.

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Race
Ethnicity
Other language

Default Content Message Here